Compounds > mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin
Page last updated: 2024-09-04

mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin and proline

mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin has been researched along with proline in 1 studies

Compound Research Comparison

Studies
(mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin)		Trials
(mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin)		Recent Studies (post-2010)
(mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin)		Studies
(proline)		Trials
(proline)		Recent Studies (post-2010) (proline)
6904222,1345205,973

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Druga, R; Folbergrová, J; Otáhal, J1

Other Studies

1 other study(ies) available for mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin and proline

ArticleYear
Brain superoxide anion formation in immature rats during seizures: protection by selected compounds.
    Experimental neurology, 2012, Volume: 233, Issue:1

    Topics: 2-Amino-5-phosphonovalerate; Animals; Animals, Newborn; Anticonvulsants; Brain; Disease Models, Animal; Homocysteine; Infusions, Intraventricular; Male; Metalloporphyrins; Proline; Rats; Rats, Wistar; Seizures; Statistics, Nonparametric; Superoxides; Time Factors

2012